Effects of insulin aspart 30 injection in treatment of hepatogenic diabetes
Liwei Bai, Suo Xin-hua, Qinggui Zhang, Lake Li
Abstract
Liwei Bai, Suo Xin-hua, Qinggui Zhang, Lake Li
Abstract
Objective To evaluate the effect of insulin aspart 30 injection and novolin 30R profile in treament of hepatogenic diabetes. Methods Forty-eight patients with hepatagenie diabetes were randomly divided into two groups: insulin aspart 30 in-jection group and novolin 30R profile group. After 12 weeks, the levels of fasting plasma glucose ( FBG), 2 hours postprandial glucose (2 Hpbg), glycosylated hemoglobin Ale (HbAlc), insulin dosages,frequency of hypoglycemia were compared before and after the treament.Results ①FBG,2 hPBG,HbAlc were significantly decreased in two groups (P 0.05).③The level of insulin dosages of insulin aspart 30 injection groups was higher than that of novolin 30R profile groups (P>0.05). Conclusion Insulin aspart 30 injection can effectively decrease 2 hour postprandial glucose and frequency of hypoglycemia in hepatogenic diabetes. Key words: Insulin aspart; Novolin; Clinical trial; Efficaey; Hepatogenie diabetes
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the effect of insulin aspart 30 injection and novolin 30R profile in treament of hepatogenic diabetes. Methods Forty-eight patients with hepatagenie diabetes were randomly divided into two groups: insulin aspart 30 in-jection group and novolin 30R profile group. After 12 weeks, the levels of fasting plasma glucose ( FBG), 2 hours postprandial glucose (2 Hpbg), glycosylated hemoglobin Ale (HbAlc), insulin dosages,frequency of hypoglycemia were compared before and after the treament.Results ①FBG,2 hPBG,HbAlc were significantly decreased in two groups (P 0.05).③The level of insulin dosages of insulin aspart 30 injection groups was higher than that of novolin 30R profile groups (P>0.05). Conclusion Insulin aspart 30 injection can effectively decrease 2 hour postprandial glucose and frequency of hypoglycemia in hepatogenic diabetes. Key words: Insulin aspart; Novolin; Clinical trial; Efficaey; Hepatogenie diabetes
Key concepts: Postprandial, Insulin aspart, Medicine, Hypoglycemia, Internal medicine, Dose, Insulin, Endocrinology